Melanoma immunoediting by NK cells

OncoImmunology

Volumn 1, Issue 9, 2012, Pages 1607-1609

  Balsamo, Mirna ^a   Pietra, Gabriella ^a   Vermi, William ^b   Moretta, Lorenzo ^c   Mingari, Maria Cristina ^a,d,e   Vitale, Massimo ^e  

^a UNIVERSITY OF GENOA   (Italy)

^b Servizio di Anatomia Patologica   (Italy)

^c G GASLINI INSTITUTE   (Italy)

^d Centro di Eccellenza per la Ricerca Biomedica   (Italy)

^e UNIVERSITY OF GENOA   (Italy)

Author keywords

Cytokines; HLA I; Immunoediting; Melanoma; NK cells

Indexed keywords

GAMMA INTERFERON; HLA ANTIGEN CLASS 1; INDOLEAMINE 2,3 DIOXYGENASE; NATURAL KILLER CELL RECEPTOR; PROSTAGLANDIN E2; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ANTIGEN EXPRESSION; CYTOKINE RELEASE; DENDRITIC CELL; ENDOTHELIUM CELL; FIBROBLAST; HOST RESISTANCE; HUMAN; IMMUNOSTIMULATION; IMMUNOSURVEILLANCE; MELANOMA; MELANOMA CELL; NATURAL KILLER CELL; NOTE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SUPPRESSOR CELL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL DESTRUCTION; TUMOR IMMUNITY; TUMOR IMMUNOEDITING;

EID: 84881281241     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.21456     Document Type: Note

References (10)

1. Zitvogel L, Tesniere A, Kroemer G. Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat Rev Immunol 2006; 6:715-27; PMID:16977338; http://dx.doi.org/10.1038/nri1936.
2. Mueller MM, Fusenig NE. Friends or foes - bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 2004; 4:839-49; PMID:15516957; http://dx.doi.org/10.1038/nrc1477.
3. Fridman WH, Pagès F, Sautès-Fridman C, Galon J. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer 2012; 12:298-306; PMID:22419253; http://dx.doi.org/10.1038/nrc3245.
4. Pietra G, Manzini C, Rivara S, Vitale M, Cantoni C, Petretto A, et al. Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity. Cancer Res 2012; 72:1407-15; PMID:22258454; http://dx.doi.org/10.1158/0008-5472.CAN-11-2544.
5. Balsamo M, Scordamaglia F, Pietra G, Manzini C, Cantoni C, Boitano M, et al. Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity. Proc Natl Acad Sci U S A 2009; 106:20847-52; PMID:19934056; http://dx.doi.org/10.1073/pnas.0906481106.
6. Vesely MD, Kershaw MH, Schreiber RD, Smyth MJ. Natural innate and adaptive immunity to cancer. Annu Rev Immunol 2011; 29:235-71; PMID:21219185; http://dx.doi.org/10.1146/annurevimmunol-031210-101324.
7. Balsamo M, Vermi W, Parodi M, Pietra G, Manzini C, Queirolo P, et al. Melanoma cells become resistant to NK-cell-mediated killing when exposed to NK-cell numbers compatible with NK-cell infiltration in the tumor. Eur J Immunol 2012; 42:1833-42; http://dx.doi.org/10.1002/eji.201142179; PMID:22585684.
8. Carosella ED, Favier B, Rouas-Freiss N, Moreau P, Lemaoult J. Beyond the increasing complexity of the immunomodulatory HLA-G molecule. Blood 2008; 111:4862-70; PMID:18334671; http://dx.doi.org/10.1182/blood-2007-12-127662.
9. Terme M, Ullrich E, Delahaye NF, Chaput N, Zitvogel L. Natural killer cell-directed therapies: moving from unexpected results to successful strategies. Nat Immunol 2008; 9:486-94; PMID:18425105; http://dx.doi.org/10.1038/ni1580.
10. Moretta L, Locatelli F, Pende D, Marcenaro E, Mingari MC, Moretta A. Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation. Blood 2011; 117:764-71; PMID:20889923; http://dx.doi.org/10.1182/blood-2010-08-264085.